503 related articles for article (PubMed ID: 33692218)
1. CXCR6 deficiency impairs cancer vaccine efficacy and CD8
Karaki S; Blanc C; Tran T; Galy-Fauroux I; Mougel A; Dransart E; Anson M; Tanchot C; Paolini L; Gruel N; Gibault L; Lepimpec-Barhes F; Fabre E; Benhamouda N; Badoual C; Damotte D; Donnadieu E; Kobold S; Mami-Chouaib F; Golub R; Johannes L; Tartour E
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33692218
[TBL] [Abstract][Full Text] [Related]
2. Functional Heterogeneity of CD4
Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
Front Immunol; 2018; 9():2654. PubMed ID: 30505306
[TBL] [Abstract][Full Text] [Related]
3. Mucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumors.
Sandoval F; Terme M; Nizard M; Badoual C; Bureau MF; Freyburger L; Clement O; Marcheteau E; Gey A; Fraisse G; Bouguin C; Merillon N; Dransart E; Tran T; Quintin-Colonna F; Autret G; Thiebaud M; Suleman M; Riffault S; Wu TC; Launay O; Danel C; Taieb J; Richardson J; Zitvogel L; Fridman WH; Johannes L; Tartour E
Sci Transl Med; 2013 Feb; 5(172):172ra20. PubMed ID: 23408053
[TBL] [Abstract][Full Text] [Related]
4. CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways.
Wein AN; McMaster SR; Takamura S; Dunbar PR; Cartwright EK; Hayward SL; McManus DT; Shimaoka T; Ueha S; Tsukui T; Masumoto T; Kurachi M; Matsushima K; Kohlmeier JE
J Exp Med; 2019 Dec; 216(12):2748-2762. PubMed ID: 31558615
[TBL] [Abstract][Full Text] [Related]
5. CXCR6 expressing T cells: Functions and role in the control of tumors.
Mabrouk N; Tran T; Sam I; Pourmir I; Gruel N; Granier C; Pineau J; Gey A; Kobold S; Fabre E; Tartour E
Front Immunol; 2022; 13():1022136. PubMed ID: 36311728
[TBL] [Abstract][Full Text] [Related]
6. Single-cell RNA transcriptome analysis of CNS immune cells reveals CXCL16/CXCR6 as maintenance factors for tissue-resident T cells that drive synapse elimination.
Rosen SF; Soung AL; Yang W; Ai S; Kanmogne M; Davé VA; Artyomov M; Magee JA; Klein RS
Genome Med; 2022 Sep; 14(1):108. PubMed ID: 36153630
[TBL] [Abstract][Full Text] [Related]
7. Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13
Hu C; You W; Kong D; Huang Y; Lu J; Zhao M; Jin Y; Peng R; Hua D; Kuang DM; Chen Y
Gastroenterology; 2024 Jun; 166(6):1069-1084. PubMed ID: 38445519
[TBL] [Abstract][Full Text] [Related]
8. Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19-IL2 cures poorly immunogenic tumors when combined with radiotherapy.
Olivo Pimentel V; Marcus D; van der Wiel AM; Lieuwes NG; Biemans R; Lieverse RI; Neri D; Theys J; Yaromina A; Dubois LJ; Lambin P
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33688020
[TBL] [Abstract][Full Text] [Related]
9. PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model.
Peng S; Tan M; Li YD; Cheng MA; Farmer E; Ferrall L; Gaillard S; Roden RBS; Hung CF; Wu TC
Cancer Immunol Immunother; 2021 Apr; 70(4):1049-1062. PubMed ID: 33108473
[TBL] [Abstract][Full Text] [Related]
10. CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis.
Lee LN; Ronan EO; de Lara C; Franken KL; Ottenhoff TH; Tchilian EZ; Beverley PC
Infect Immun; 2011 Aug; 79(8):3328-37. PubMed ID: 21628524
[TBL] [Abstract][Full Text] [Related]
11. Induction of Progenitor Exhausted Tissue-Resident Memory CD8
León-Letelier RA; Castro-Medina DI; Badillo-Godinez O; Tepale-Segura A; Huanosta-Murillo E; Aguilar-Flores C; De León-Rodríguez SG; Mantilla A; Fuentes-Pananá EM; López-Macías C; Bonifaz LC
Front Immunol; 2020; 11():583382. PubMed ID: 33240271
[TBL] [Abstract][Full Text] [Related]
12. Induction of resident memory T cells enhances the efficacy of cancer vaccine.
Nizard M; Roussel H; Diniz MO; Karaki S; Tran T; Voron T; Dransart E; Sandoval F; Riquet M; Rance B; Marcheteau E; Fabre E; Mandavit M; Terme M; Blanc C; Escudie JB; Gibault L; Barthes FLP; Granier C; Ferreira LCS; Badoual C; Johannes L; Tartour E
Nat Commun; 2017 May; 8():15221. PubMed ID: 28537262
[TBL] [Abstract][Full Text] [Related]
13. STING Agonist Combined to a Protein-Based Cancer Vaccine Potentiates Peripheral and Intra-Tumoral T Cell Immunity.
Rossi M; Carboni S; Di Berardino-Besson W; Riva E; Santiago-Raber ML; Belnoue E; Derouazi M
Front Immunol; 2021; 12():695056. PubMed ID: 34276686
[TBL] [Abstract][Full Text] [Related]
14. CXCR6 by increasing retention of memory CD8
Muthuswamy R; McGray AR; Battaglia S; He W; Miliotto A; Eppolito C; Matsuzaki J; Takemasa T; Koya R; Chodon T; Lichty BD; Shrikant P; Odunsi K
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34607898
[TBL] [Abstract][Full Text] [Related]
15. CD103
Corgnac S; Malenica I; Mezquita L; Auclin E; Voilin E; Kacher J; Halse H; Grynszpan L; Signolle N; Dayris T; Leclerc M; Droin N; de Montpréville V; Mercier O; Validire P; Scoazec JY; Massard C; Chouaib S; Planchard D; Adam J; Besse B; Mami-Chouaib F
Cell Rep Med; 2020 Oct; 1(7):100127. PubMed ID: 33205076
[TBL] [Abstract][Full Text] [Related]
16. CXCR6 is required for antitumor efficacy of intratumoral CD8
Wang B; Wang Y; Sun X; Deng G; Huang W; Wu X; Gu Y; Tian Z; Fan Z; Xu Q; Chen H; Sun Y
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34462326
[TBL] [Abstract][Full Text] [Related]
17. In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
Oba T; Makino K; Kajihara R; Yokoi T; Araki R; Abe M; Minderman H; Chang AE; Odunsi K; Ito F
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049930
[TBL] [Abstract][Full Text] [Related]
18. IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors.
Beyranvand Nejad E; Labrie C; van Elsas MJ; Kleinovink JW; Mittrücker HW; Franken KLMC; Heink S; Korn T; Arens R; van Hall T; van der Burg SH
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33879600
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells maintain anti-tumor immunity by positioning CD8 skin-resident memory T cells.
Vella JL; Molodtsov A; Angeles CV; Branchini BR; Turk MJ; Huang YH
Life Sci Alliance; 2021 Oct; 4(10):. PubMed ID: 34362825
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral delivery of an HPV vaccine elicits a broad anti-tumor immune response that translates into a potent anti-tumor effect in a preclinical murine HPV model.
Ishida E; Lee J; Campbell JS; Chakravarty PD; Katori Y; Ogawa T; Johnson L; Mukhopadhyay A; Faquin WC; Lin DT; Wirth LJ; Pierce RH; Pai SI
Cancer Immunol Immunother; 2019 Aug; 68(8):1273-1286. PubMed ID: 31243491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
